| Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F RM Bandaranayake, D Ungureanu, Y Shan, DE Shaw, O Silvennoinen, ... Nature structural & molecular biology 19 (8), 754-759, 2012 | 263 | 2012 |
| Molecular basis for drug resistance in HIV-1 protease A Ali, RM Bandaranayake, Y Cai, NM King, M Kolli, S Mittal, JF Murzycki, ... Viruses 2 (11), 2509-2535, 2010 | 172 | 2010 |
| Drug resistance conferred by mutations outside the active site through alterations in the dynamic and structural ensemble of HIV-1 protease DA Ragland, EA Nalivaika, MNL Nalam, KL Prachanronarong, H Cao, ... Journal of the American Chemical Society 136 (34), 11956-11963, 2014 | 105 | 2014 |
| Extreme entropy–enthalpy compensation in a drug-resistant variant of HIV-1 protease NM King, M Prabu-Jeyabalan, RM Bandaranayake, MNL Nalam, ... ACS chemical biology 7 (9), 1536-1546, 2012 | 99 | 2012 |
| Noble metals strip peptides from class II MHC proteins SL De Wall, C Painter, JD Stone, R Bandaranayake, DC Wiley, ... Nature chemical biology 2 (4), 197-201, 2006 | 85 | 2006 |
| New insights into the structure and function of the pseudokinase domain in JAK2 O Silvennoinen, D Ungureanu, Y Niranjan, H Hammaren, ... Biochemical Society Transactions 41 (4), 1002-1007, 2013 | 54 | 2013 |
| The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways RM Bandaranayake, M Kolli, NM King, EA Nalivaika, A Heroux, ... Journal of virology 84 (19), 9995-10003, 2010 | 49 | 2010 |
| Structural analysis of human immunodeficiency virus type 1 CRF01_AE protease in complex with the substrate p1-p6 RM Bandaranayake, M Prabu-Jeyabalan, J Kakizawa, W Sugiura, ... Journal of virology 82 (13), 6762-6766, 2008 | 22 | 2008 |
| Synthesis of symmetrically and asymmetrically branched pegylating reagents AM Felix, RM Bandaranayake The Journal of peptide research 63 (2), 85-90, 2004 | 5 | 2004 |
| Circumventing drug resistance: using the substrate envelope hypothesis to develop robust novel HIV1 protease inhibitors MNL Nalam, A Ali, K Reddy, M Altman, S Chellappan, R Bandaranayake, ... ANTIVIRAL THERAPY 12, S138-S138, 2007 | 4 | 2007 |
| Synthesis of bis‐ and tris‐branched COOH‐terminal pegylating reagents: conjugation to NH2‐terminal peptides AM Felix, RM Bandaranayake The Journal of peptide research 65 (1), 71-76, 2005 | 3 | 2005 |
| Differential resistance in HIV-1 protease: the role of residue 50 in pathways for amprenavir/darunavir and atazanavir resistance RM Bandaranayake, S Mittal, NM King, M Prabu-Jeyabalan, MNL Nalam, ... ANTIVIRAL THERAPY 15 (4), A14-A14, 2010 | 1 | 2010 |
| Crystal structure of lysine sulphonamide inhibitor reveals the displacement of the conserved flap water molecule in HIV-1 protease MNL Wain, R Bandaranayake, A Peeters, THM Jonckers, I Dierynck, ... Deakin University, 2007 | 1 | 2007 |
| Exploring Molecular Mechanisms of Drug Resistance in HIV-1 Protease through Biochemical and Biophysical Studies: A Dissertation RM Bandaranayake | | 2010 |
| Molecular Basis for Drug Resistance in HIV-1 Protease CA Schiffer, K Thayer, EA Nalivaika, A Özen, MM Prabu-Jeyabalan, ... | | 2010 |
| Structural Explanations to Altered Drug Resistance Pathways in HIV-1 Non-Clade B Proteases RM Bandaranayake, M Kolli, M Prabu-Jeyabalan, M Nalam, C Ng, ... Biophysical Journal 96 (3), 447a, 2009 | | 2009 |
| Structural and biochemical insights into altered drug resistance pathways in non-clade B HIV-1 proteases RM Bandaranayake, E Nalivaika, M Kolli, J Kakizawa, A Heroux, NM King, ... ANTIVIRAL THERAPY 14 (4), A111-A111, 2009 | | 2009 |
| Structural Analysis of Human WS Kakizawa, CA Schiffer, RM Bandaranayake, ... J. Virol 82 (13), 6762, 2008 | | 2008 |
